CORC

在结果中检索

CORC

浏览/检索结果: 共39条，第1-10条 帮助

已选(0)清除 条数/页：   排序方式：
Treating relapsed/refractory mature T- and NK-cell neoplasms with tislelizumab: a multicenter open-label phase 2 study 期刊论文
BLOOD ADVANCES, 2023, 卷号: 7
作者:  Bachy, Emmanuel;  Savage, Kerry J.;  Huang, Huiqiang;  Kwong, Yok-Lam;  Gritti, Giuseppe
收藏  |  浏览/下载：9/0  |  提交时间：2023/11/10
Tislelizumab, a PD-1 inhibitor for relapsed/refractory mature T/NK-cell neoplasms: Results from a phase 2 study. 期刊论文
JOURNAL OF CLINICAL ONCOLOGY, 2022, 卷号: 40
作者:  Bachy, Emmanuel;  Savage, Kerry J.;  Huang, Huiqiang;  Kwong, Yok-Lam;  Gritti, Giuseppe
收藏  |  浏览/下载：17/0  |  提交时间：2022/12/23
Zanubrutinib monotherapy for relapsed or refractory non-germinal center diffuse large B-cell lymphoma 期刊论文
BLOOD ADVANCES, 2022, 卷号: 6
作者:  Yang, Haiyan;  Xiang, Bing;  Song, Yuqin;  Zhang, Huilai;  Zhao, Weili
收藏  |  浏览/下载：14/0  |  提交时间：2022/12/23
Tislelizumab for Relapsed/Refractory Classical Hodgkin Lymphoma: 3-Year Follow-up and Correlative Biomarker Analysis 期刊论文
CLINICAL CANCER RESEARCH, 2022, 卷号: 28
作者:  Song, Yuqin;  Gao, Quanli;  Zhang, Huilai;  Fan, Lei;  Zhou, Jianfeng
收藏  |  浏览/下载：28/0  |  提交时间：2022/05/05
Tislelizumab (BGB-A317) for relapsed/refractory (R/R) classical Hodgkin lymphoma (cHL): Long-term follow-up efficacy and safety results from a phase 2 study. 期刊论文
JOURNAL OF CLINICAL ONCOLOGY, 2021, 卷号: 39
作者:  Song, Yuqin;  Gao, Quanli;  Zhang, Huilai;  Fan, Lei;  Zhou, Jianfeng
收藏  |  浏览/下载：28/0  |  提交时间：2022/01/10
S100A11 Promotes Liver Steatosis via FOXO1-Mediated Autophagy and Lipogenesis 期刊论文
CELLULAR AND MOLECULAR GASTROENTEROLOGY AND HEPATOLOGY, 2021, 卷号: 11, 期号: 3, 页码: 697-724
作者:  Zhang, Linqiang;  Zhang, Zhiguo;  Li, Chengbin;  Zhu, Tingting;  Gao, Jing
收藏  |  浏览/下载：45/0  |  提交时间：2021/05/24
Primary breast diffuse large B-cell lymphoma in the rituximab era: therapeutic strategies and patterns of failure (vol 109, pg 3943, 2018) 期刊论文
CANCER SCIENCE, 2019, 卷号: 110, 期号: 4
作者:  Xiao, Xiubin;  Bao, Huizheng;  Wang, Ningju;  Ren, Hanyun;  Cen, Xinan
收藏  |  浏览/下载：56/0  |  提交时间：2019/12/05
AUGMENT: A Phase III Study of Lenalidomide Plus Rituximab Versus Placebo Plus Rituximab in Relapsed or Refractory Indolent Lymphoma 期刊论文
JOURNAL OF CLINICAL ONCOLOGY, 2019, 卷号: 37, 期号: 14
作者:  Leonard, John P.;  Trneny, Marek;  Izutsu, Koji;  Fowler, Nathan H.;  Hong, Xiaonan
收藏  |  浏览/下载：25/0  |  提交时间：2019/12/05
Pralatrexate in Chinese Patients with Relapsed or Refractory Peripheral T-cell Lymphoma: A Single-arm, Multicenter Study 期刊论文
TARGETED ONCOLOGY, 2019, 卷号: 14, 期号: 2
作者:  Hong, Xiaonan;  Song, Yuqin;  Huang, Huiqiang;  Bai, Bing;  Zhang, Huilai
收藏  |  浏览/下载：23/0  |  提交时间：2019/12/05
Shale pore characterisitcs of Shahejie Formation: Implication for pore evolution of shale oil reservoirs in Dongying sag, North China 期刊论文
Petroleum Research, 2019
作者:  Shun Zhang;  Huimin Liu;  Min Wang;  Xinjin Liu;  Huilai Liu
收藏  |  浏览/下载：9/0  |  提交时间：2019/12/17

©版权所有 ©2017 CSpace - Powered by CSpace